Search
Patexia Research
Case number 1:23-cv-00548

Acerta Pharma B.V. et al v. Alembic Pharmaceuticals Limited et al > Summary

Court Case Number 1:23-cv-00548

Filing Date May 19, 2023

Termination Date Jun 5, 2024

Court Delaware District Court

Status Judgment - Judgment on Consent

JudgesGregory B. Williams

Plaintiff

3

AstraZeneca

Acerta Pharma

Merck Sharp & Dohme

Defendant

2

Alembic Pharmaceuticals, Inc.

Alembic Pharmaceuticals Ltd.

Related Patents

Doc No Title Issue date
10272083 Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor Apr 30, 2019
10239883 4-imidazopyridazin-1-yl-benzamides as BTK inhibitors Mar 26, 2019
10167291 Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide Jan 1, 2019
09758524 4-imidazopyridazin-1-yl-benzamides as Btk inhibitors Sep 12, 2017
Menu